NCT04026737 2026-02-09
CVE-CART
Abramson Cancer Center at Penn Medicine
Completed
Clinical Trials
14 trialsNCT02916316 2025-11-18
Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell
Fondazione Italiana Linfomi - ETS
Completed
NCT04737265 2025-07-03
NTproBNP-Guide
Abramson Cancer Center at Penn Medicine
Phase 1/2 Completed
NCT07041827 2025-06-27
CLARITY
The Netherlands Cancer Institute
Completed
NCT03760237 2024-10-10
Cardiovascular Function in Acute Leukemia
Abramson Cancer Center at Penn Medicine
Completed
NCT00577798 2023-11-03
Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin
University of Nebraska
Completed
NCT05130489 2023-05-12
CARTCO
University College London Hospitals
Completed
NCT03480087 2022-07-19
Cardiocare
A.O.U. Città della Salute e della Scienza
Completed
NCT03235427 2019-05-21
CAROLE
Northwell Health
Completed
NCT00854568 2014-08-20
Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL
Fudan University
Phase 3 Completed
NCT00005578 2014-07-24
Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease
Children's Oncology Group
Phase 3 Completed
NCT00002827 2013-08-26
Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease
Children's Oncology Group
Phase 3 Completed
NCT01095926 2013-06-28
Doxo
University Hospital Muenster
Phase 2 Completed
NCT01230983 2013-06-06
T-Cell #4
Children's Oncology Group
Phase 3 Completed